Perrigo Company plc splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Consumer Self Care Americas at $2.6 billion, 61% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 26, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2016
Dec 31, 2016
|
FY 2016
Jun 27, 2015
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4,090
|
4,253
|
4,373
|
4,656
|
4,452
|
4,139
|
4,088
|
3,870
|
4,732
|
5,281
|
4,227
|
| Consumer Self Care Americas |
—
|
2,585
-4.0%
share 60.8%
|
2,694
-9.1%
share 61.6%
|
2,962
+1.2%
share 63.6%
|
2,926
+8.6%
share 65.7%
|
2,693
+0.0%
share 65.1%
|
2,693
+8.3%
share 65.9%
|
2,488
+3.2%
share 64.3%
|
2,412
share 51.0%
|
—
|
—
|
| Consumer Self Care International |
—
|
1,668
-0.7%
share 39.2%
|
1,680
-0.8%
share 38.4%
|
1,693
+11.0%
share 36.4%
|
1,526
+5.5%
share 34.3%
|
1,446
+3.6%
share 34.9%
|
1,395
+0.9%
share 34.1%
|
1,382
-1.2%
share 35.7%
|
1,399
share 29.6%
|
—
|
—
|
| RX Pharmaceuticals |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
968
+5.1%
share 25.0%
|
921
share 19.5%
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRGO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin 2, Ireland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1585364
- Former names
- PERRIGO Co Ltd (until Nov 12, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.